ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn
Tip: Access up to 7 years of quarterly data
All positions including ALNYLAM PHARMACEUTICALS INC. Common Stock cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $12M | 63k | 191.41 |
2023-09-30 | $7.1M | 40k | 177.10 |
2023-06-30 | $9.5M | 50k | 189.94 |
2023-03-31 | $10M | 50k | 200.32 |
2022-12-31 | $9.5M | 40k | 237.65 |
2022-06-30 | $1.7M | 12k | 145.88 |
2022-03-31 | $1.9M | 12k | 163.28 |
2021-12-31 | $14M | 83k | 169.58 |
2020-03-31 | $2.2M | 20k | 108.85 |
2019-03-31 | $1.7M | 18k | 93.44 |
2018-09-30 | $2.6M | 30k | 87.53 |
2018-06-30 | $2.7M | 27k | 98.48 |
2018-03-31 | $3.2M | 27k | 119.11 |
Top funds holding ALNYLAM PHARMACEUTICALS INC. Common Stock cmn
View all funds holding ALNYLAM PHARMACEUTICALS INC. Common Stock cmn